AGGAME

Ê×Ò³ ·þÎñÖÐÐÄ ÒÒ¸ÎÔ°µØ

ëì·´É俺½ø

Ðû²¼£º2016-03-03¡¡|¡¡ÈªÔ´£º»¥ÁªÍø¡¡|¡¡ä¯ÀÀ£º17849

¡¾ëì·´É俺½ø¡¿ÊÇʲô

Éî·´ÉäÊǴ̼¤¼¡ëì¡¢¹ÇĤ¸ÐÊÜÆ÷ËùÒýÆðµÄ·´Éä £¬Í¨³£³ÆÎªëì·´Éä¡£Ò»Ñùƽ³£½«ëì·´ÉäµÄ»îԾˮÖзÖΪ£º¢ÙÏûÊÅ(-)£º²»·ºÆð·´Éä;¢Ú»ºÂý(+)£ºµÍÓÚÕý³£µÄ·´Ó¦;¢ÛÕý³£(++);¢Ü»îÔ¾(+++);¸ßÓÚÕý³£µÄ·´Ó¦;¢Ý¿º½ø(++++);·´ÉäÇ¿ £¬÷ÆÕðÂΡ¢õ×ÕðÂÎÑôÐÔ¡£

¡¾ëì·´É俺½ø¡¿ÊÇÔõôÒýÆðµÄ

ëì·´É俺½øÎ»ÓÚ·´ÉäµÄ¼¹ËèÖÐÊàÉÏ·½µÄ×¶ÌåÊøÊÜÀÛʱ £¬·ºÆðëì·´É俺½ø¡£Éî·´É俺½ø £¬¼ûÓÚ×¶ÌåÊøÊÜËðµÈÉÏÔ˶¯Éñ¾­ÔªÌ±»¾ £¬»ò¼ûÓÚ¼××´ÅÔÏÙ¹¦Ð§¿º½ø¡¢Éñ¾­ÏµÍ³ÐË·ÜÐÔÔö¸ßµÈ¡£

¡¾ëì·´É俺½ø¡¿ÏêϸÆÊÎö

ͨ³£ÇéÐÎÏ £¬ÁÙ´²ÉÏͨ¹ýÒÔϼ¸ÖÖÒªÁìÀ´×ÛºÏÅжÏ¡£ÏÈÊÇ×óÓÒ½ÏÁ¿ £¬ÈôÊÇÁ½²àëì·´Éä¾ù½Ï´ó £¬ÇÒÆäÖÐÒ»²à½ÏÁíÒ»²à¸üÏÔ×Åʱ £¬¿ÉÒÔÒÔΪ·´Éä¸üÏÔ×ŵÄÕâ²àÊôÉî·´É俺½ø¡£

¿ÉÊÇ £¬ÓÐЩÇéÐÎÊÇÒ»²à±ÈÕý³£ëì·´É俺½øÉÔÈõ £¬¶øÁíÒ»²à±ÈÕý³£ëì·´ÉäÉÔÇ¿¡£´ËʱÅжϾÍÏà¶Ô½ÏÄÑ £¬½öͨ¹ý·´ÉäºÜÄÑÃ÷È·ÄÄÒ»²à²»Õý³£ £¬´ËʱҪÍŽáÉñ¾­ÏµÍ³ÆäËûÌåÕ÷À´×ÛºÏÅжÏ¡£

ÖÚËùÖÜÖª £¬Éî·´ÉäÁ½²àÓ¦µ±ÊÇÒ»Ö嵀 £¬¿Éµ±Ë«²àÉî·´Éä¾ù»îÔ¾ÇÒ¶Ô³ÆÊ± £¬ÒªÅжÏÊÇÉî·´Éä»îÔ¾ÕÕ¾ÉÉî·´É俺½øÊ± £¬¾ÍÒªÊӲ췴ÉäËùÒýÆð¼¡ÈâËõ¶ÌÊÇ·ñÓÐÒ»Á¬µÄ½ÚÂÉÐÔ £¬Ò²¾ÍÊÇÓôòÕﴸߵ»÷¼¡ëì»ò¹ÇĤ £¬ËäÈ»½öÊÇÒ»´Îßµ»÷ £¬È»¶ø·´ÉäÐԵļ¡ÈâËõ¶ÌÈ´²»ÊÇÒ»´Î £¬¶øÊÇÒ»Á¬µÄÖØ¸´Õð²ü £¬ÁÙ´²ÉϳƶදÐÔ·´Éä £¬ÈôÊÇ·ºÆð¶à¶¯ÐÔ·´Éä £¬Ôò¿ÉÒÔÒÔΪÊÇÉî·´É俺½ø £¬Îª²¡ÀíÐÔ¡£ÁíÒ»ÖÖÇéÐξÍÊÇÕóÂÎ £¬µ±ëì·´É伫¶Ë¿º½øÊ±·ºÆð £¬Ò²Îª²¡ÀíÐÔ £¬ÁÙ´²Éϳ£¼ûµÄÓÐ÷ÆÕóÂκÍõ×ÕóÂΡ£ÁíÍâ £¬µ±ßµ»÷¼¡ëìʱ £¬ÈôÊÇÒ»´Îßµ´ò £¬¼´¿É¼ûµ½·´ÉäÐÔÔ˶¯µÄÕñ·ùºÜÊÇ´ó £¬ÇÒËÙÂʼ«¿ìʱ £¬Ò²¿ÉÒÔÒÔΪÊÇ·´É俺½ø £¬ÓÈÆäÊÇËÙÂʼ«Ö÷Òª¡£ÔÙÓоÍÊÇͨ³£ÇéÐÎÏÂÔÚÕý·²È˼û²»µ½µÄ·´Éä £¬»ò×ÝÈ»±£´æÒ²ºÜÈõµÄ·´Éä±»ÓÕ·¢³öÀ´Ê± £¬Ò²¿ÉÒÔÒÔΪÊÇÉî·´É俺½ø £¬ºÃ±ÈÍ·ºóÇü·´Éä¡¢Ö¸ÓÞÃÁ·´Éä¡¢ÏÂò¦·´ÉäµÈ¡£

×¶ÌåÊøÊÜËðʱµÄÌåÏÖ £¬³Æ²¡Àí·´Éä¡£·ºÆð²¡Àí·´ÉäÒ»¶¨ÎªÖÐÊàÉñ¾­ÏµÍ³ÊÜËð¡£ÁÙ´²ÉÏÖ÷ÒªµÄ²¡Àí·´ÉäÓÐÒÔϼ¸ÖÖ£º

(Ò»)¼¡Î®Ëõ²àË÷Ó²»¯(amyotrophic lateral sclerosis) ÔçÆÚÒ»²àÉÏÖ«Ô˶˼¡ÈâήËõ £¬Öð½¥·ºÆðÆäËüÖ«Ì弡ήËõ £¬ÏÂÖ«¼°Çû¸Éż¿ÉÊÜÀÛ £¬ºóÃæ¼¡¼°É༡ÊÜÀ۲ŷºÆðήËõ £¬1-2Äê²ÅÉú³¤µ½È«Éí¼¡Î®Ëõ¡£ÔçÆÚ×¶ÌåÊøË𺦲»ÏÔ×Å £¬¹ÊÔçÆÚÕï¶Ï½ÏÄÑÌâ £¬±ØÐèÓÐÃ÷È·µÄ×¶ÌåÊøÕ÷²Å¿ÉÈ·Õï¡£Ô¼°ëÊýÒÔÉÏÓÐBabinskiÕ÷ £¬ÎÞ¸ÐÊÜÕϰ­¼°¾Þϸ±ãʧ½û £¬±¬·¢Èì´¯ÕßÓÐÊý £¬ÔçÆÚÓÐÒÏÐиС¢ÌÛÍ´µÈ¡£

(¶þ)ÄÔ³öѪ(cerebral haemorrhage) ¶àÓиßѪѹ²¡Ê· £¬³£ÔÚ50¡«60Ëê·¢²¡ £¬ÌåÁ¦Ô˶¯»òÇéÐ÷¼¤¶¯Ê±Í»È»Æð²¡ £¬Éú³¤Ñ¸ËÙ £¬ÔçÆÚÓÐÍ·Í´¡¢ÍÂÄæµÈ­ÄÚѹÔö¸ßÕ÷Ïó £¬ÒâʶÕϰ­ £¬°éÓÐÄÔĤ´Ì¼¤Õ÷¼°Æ«Ì±¡¢Ê§ÓïµÈÄÔ¾Ö²¿Ö¢×´ £¬²¡Çé¼ÓÖØ¿É·ºÆð»èØÊ £¬ËÄÖ«¼¡ÕÅÁ¦µÍ £¬±ÇÉùºôÎü £¬Öظ´ÍÂÄæ £¬³£ÓÐË«²àÍ«¿×²»µÈ´ó £¬Ò»Ñùƽ³£Îª³öѪ²àÍ«¿×À©´ó £¬²¿·Ö²¡ÀýÁ½ÑÛÏò³öѪ²à×¢ÊÓ £¬³öѪÔîµÄ¶Ô²àƫ̱ £¬¼¡ÕÅÁ¦Æ«µÍ £¬°Í±ò˹»ùÕ÷ÑôÐÔ¡£Õë´Ì̱»¾²àÎÞ·´Ó¦¡£Ñü´©¿É³ÊѪÐÔÄÔ¼¹Òº £¬CTÏÔʾ¸ßÃܶÈÔî¡£MRI¡¢T1W¡¢T2WÄÔÄÚ¸ßÐźÅÇø¡£

(Èý)ÄÔѪ˨ÐγÉ(cerebral thrombosis) ¶à·¢ÓÚ60ËêÒÔÉÏÍíÄêÈË £¬°éÓиßѪѹ²¡Ê·¼°ÄÔ¶¯ÂöÓ²»¯Õߺ͹ÚÐIJ¡»òÌÇÄò²¡Ê· £¬ÄÐÐÔ¶àÓÚÅ®ÐÔ¡£³£ÓÚ˯ÃßÖлòÇå¾²ÐÝϢʱ·¢²¡ £¬1-4ÌìÄÚ´ïá¯Áë¡¢»èØÊ½ÏÇá £¬Í·Í´¡¢ÍÂÄæÕßÉÙ¼û £¬Í«¿×ÎÞת±ä £¬ÑÛµ×¶¯ÂöÓ²»¯ £¬²¡Ôî¶Ô²àÖ«Ìå̱»¾ £¬³£·ºÆðƫ̱¡¢Ê§ÓƫÉí¸ÐÊÜÕϰ­¡¢Æ«Ã¤µÈ¡£¾±²¿ÓжԿ¹ £¬¼¡ÕÅÁ¦µÍ £¬²¡²à°Í±ò˹»ùÕ÷¡¢¿¨µÀ¿ËÕ÷¼°¸ß¶ûµÇÕ÷ÑôÐÔ¡£ÄÔ¼¹Òº¼ì²é¶àÕý³£ £¬Â­ÄÔCTÏÔʾµÍÃܶÈÇø¡£MRI¡¢T1MµÍÐźÅÇø £¬T2MÉÔ¸ßÐźÅÇø¡£

(ËÄ)¶à·¢ÐÔÓ²»¯(multiple sclerosis) ¶àÔÚ20-40ËêÖ®¼ä·¢²¡ £¬ºÜÉÙÔÚ10ËêÒÔÏÂ(3%)¼°50ËêÒÔÉÏ(5%)·¢²¡Õß £¬Å®ÐÔ¶àÓÚÄÐÐÔ¡£¶àÓлº½âÓ븴·¢²¡Ê· £¬¶àÓи´ÊÓ £¬µ¥²à»òË«²àÖ«ÌåÎÞÁ¦ £¬Ö«ÌåµÄ¸ÐÊÜÒì³£ £¬×¶ÌåÊøÊÜËð¿É·ºÆð¾·ÂÎÐÔÖ«Ìå̱ £¬¿ÉÌåÏÖΪ½ØÌ±¡¢ËÄ̱֫Èý̱֫¡¢Æ«Ì±»òµ¥Ì± £¬ëì·´É俺½ø £¬BabinskiÕ÷ÑôÐÔ¡£

(Îå)Á¼ÐÔÊ¢ÐÐÐÔÉñ¾­¼¡ÎÞÁ¦(benign epidmic neural myasthenia) ³õÆÚ¿ÉÓеÍÈÈ»òÎÞ·¢ÈÈ £¬Ç±ÔÚÆÚÔ¼1ÖÜ×óÓÒ £¬°éÓÐÉϺôÎüµÀѬȾ £¬ÑÊÍ´¡¢Î¸³¦µÀÖ¢×´µÈ¡£È«ÉíÁÜͶºÏÖ×´ó £¬ÒÔ¾±²¿ÁÜͶºÏÖ×´óÏÔ×Å £¬Éñ¾­ÏµÍ³ÊÜÀÛÕ߲෺ÆðÍ·Í´¡¢¾±Ó²¼°¾±Í´¡¢¼¡ÈâÍ´¡£ÑÛÇòÕð²ü £¬¸´ÊÓ £¬¼¡ÕóÂÎ £¬ÑÊºí²¿¼¡ÎÞÁ¦ £¬Ö«ÌåÈíÈõ·¦Á¦ £¬ëì·´ÉäÕý³£¡¢¿º½ø»ò¼õÍË £¬²¡ÀíÕ÷ÑôÐÔ¡£¼¡Êø²ü¶¶ £¬°éÓм¡ÈâÌÛÍ´¼°Ñ¹Í´ £¬Æ¤·ô¸ÐÊܹýÃô¡£Ê§Ãß¼°¶àÃΡ¢ÇéÐ÷²»ÎÈ¡¢×¢ÖØÁ¦²»¼¯ÖÐ £¬ÓôÃÆ¡¢ñ¯²¡Ñù±¬·¢µÈ¡£

(Áù)¸ßѪѹÄÔ²¡(hypertensiver encephalopathy) ¶à¼ûÓÚ¼±½øÐÍ»òÑÏÖØ»º½øÐ͸ßѪѹ²¡ÈË £¬ÌåÏÖΪǿÁÒµÄÍ·Í´¡¢Í·ÔΡ¢ÍÂÄæ¡¢Í·ÕÍ»ò¾«ÉñÅÓÔÓ¡£±¾²¡µÄÖÜÈ«Éú³¤¿ÉÄÜÐèÒª12¡«48Сʱ £¬Ò7ἮðÈ«ÉíÐԳ鴤 £¬¼¡ÕóÂÎ £¬»èØÊ¼°¾ÖÔîÐÔÉñ¾­Õϰ­ £¬²¢¿É·ºÆð°ëÉíÇá̱¡¢Ê§Óï¡¢¾ÖÔîÐÔñ²ðﱬ·¢ÒÔ¼°ÊÓÍøÄ¤ÐÔ»òƤÖÊÐÔʧÃ÷ £¬Ò²¿É·ºÆðÊÓÈéÍ·Ë®Ö× £¬ÊÓÍøÄ¤³öѪ¼°ÉøÍ¸ £¬ÑªÑ¹Í»È»Éý¸ß¡£²¡Àí·´ÉäÑôÐÔ¡£Ñü´©ÄÔ¼¹Òº¶àÕý³£ £¬Ñ¹Á¦Ôö¸ß¡£

(Æß)¶à·¢ÐÔÄÔ¹£Èû³Õ´ô(dementiacaused multiple cerebral infarcion) Ö÷ÒªÖ¢×´ÓÐÓ°ÏóÁ¦¼õÍË £¬ÖÇÁ¦»ºÂý £¬¶¨ÏòÁ¦Õϰ­ £¬ÅжÏÁ¦²î¼°È±·¦×ÔÖªÁ¦¡£½üÓ°ÏóÏÔ׿õÍË £¬ÈÝÒ×ÒÅÍü £¬µ«Ô¶Ó°ÏóÒ»Ñùƽ³£¼á³Ö½ÏºÃ £¬¶ÔºÜÊìµÄÈ˲»ÊìϤ £¬°Ñʱ¼äËùÔÚŪ´í¡£×¨ÒµÖªÊ¶Ò²ÒÅÍü £¬ÅÌËãÁ¦²î £¬ÓïÑԴʲ»´ïÒâ £¬ÉõÖÁ²»Á¬¹á £¬¾«ÉñÀäµ­ £¬·´Ó¦»ºÂý¡¢×Ô˽×ÔÀû £¬×ÔÎÒÖÐÐÄ £¬°éÓÐÇéÐ÷²»ÎÈ¹Ì £¬ÐÔÇé¼±Ôê £¬¶àÒÉ £¬ÍýÏëµÈ¡£ÍíÆÚÓгմô £¬è㶯Âö¡¢×ã±³¶¯Âö¡¢¹É¶¯ÂöÁ½²à²«¶¯Õý³£ £¬¿ÉÌýµ½Ñª¹ÜÔÓÒô¡£ëì·´ÉäÔö¸ß £¬Ë«²àBabinskiÕ÷ÑôÐÔ¡£ÕÆò¤·´Éä¡¢Îü˱·´É䡢ü¼ä·´ÉäÑôÐÔ¡£

(°Ë)ÆÏÌÑĤ´óÄÔÑ×( uveoencephalitis) ·¢²¡ÄêËêÒÔ25-50Ëê¶à¼û £¬³£ÓÚ´ºÌì·¢²¡¡£ÏÈÓÐÄÔĤ´Ì¼¤Ö¢×´¡¢ÊÈ˯¡¢ÒâʶÕϰ­ £¬Å¼¿ÉÓÐÆ«Ì±ºÍʧÓƫ̱²à¼¡ÕÅÁ¦Ôö¸ß £¬ëì·´ÉäÔöÇ¿ £¬°Í±ò˹»ùÕ÷ÑôÐÔ¡£·¢²¡1-2ÖÜ·ºÆð¼±ÐÔÃÖÂþÐÔÆÏÌÑĤÑ× £¬ÊÓÁ¦Öè¼õ £¬½Þ×´Ìå³äѪ £¬ºçĤºóÕ³Á¬ £¬Í«¿×ËõС £¬²£Á§Ìå»ì×Ç £¬»òÊÓÍøÄ¤¸¡Öס£ÊÓÈéÍ·³äѪ £¬±ßÑØ²»Çå £¬ÉõÖÁÊÓÍøÄ¤°þÀë¡£ÉпɷºÆð¶úÃù¡¢¶úÁûÇå¾²ºâÕϰ­¡ £¿É·ºÆðƤ·ô°×°ß¡¢º×·¢ºÍÍÑ·¢µÈ¡£

(¾Å)¸ÎÐÔ¼¹Ë財(hepatic myelopathy) ±¾²¡ÏÖʵÉϲ¢²»ÉÙ¼û £¬Òò´ó¶¼²¡È˸ÎÐÔÄÔ²¡²¢´æ £¬ÁÙ´²Ö¢×´±»ÄÔ²¡µÄÒâʶ¼°Ô˶¯Õϰ­ËùÑÚÊζøÎóÕï¡£²¡Àí¼ì²é·¢Ã÷¼¹ËèºóÊø¡¢²àÊøµÄÍÑËèÇʸıä¡£´Ë²¡·¢²¡»ºÂý £¬¾ÙÐÐÐÔ¼ÓÖØ £¬Ë«ÏÂÖ«ÎÞÁ¦¡¢×ß·²»ÎÈ £¬¿É°éÓÐÀ¨Ô¼¼¡Õϰ­¡£Ë«ÏÂÖ«¼¡Á¦ £¬¼õÍË¡¢¼¡ÕÅÁ¦Ôö¸ß £¬ëì·´É俺½ø³£ÓÐÕóÂÎ £¬²¡Àí·´ÉäÑôÐÔ¡£Òô²æÕ𾪼°ÊàŦλÖþõ¼õÍË £¬Í´¡¢´¥¾õÕý³£¡£Ì±»¾Ö«Ì弡Á¦3-4¼¶¡£ÍêÈ«ÐÔ½ØÌ±ÉÙ¼û £¬ÎÞÏÔ×ŵIJ¡Ëð¸ÐÊÜˮƽ¡£Ñª°±Éý¸ß¡£

(Ê®)ÑǼ±ÐÔÍŽá±äÐÔ(subacute combined degeneration) ±¾²¡ÎÞÏÔ×ŵļÒ×åÊ·»òÐÔ±ð²î±ð¡£¶àÔÚÖÐÄêÂýÐÔÆð²¡ £¬½¥½øÐÔ¼ÓÖØ £¬ÔçÆÚ×ãÖº¼°ÊÖÖ¸×îºó¶Ô³ÆÐÔ¸ÐÊÜÒì³£ £¬½¥Ïò½ü¶ËÉìÑÓ¡£Á½ÏÂÖ«ÎÞÁ¦ £¬¼¡ÕÅÁ¦¼õµÍ £¬Çá¶È¼¡Î®Ëõ £¬ëì·´É仺Âý¡£Éîdz¸ÐÊܾù¿É·ºÆðÕϰ­ £¬³ÊÖÜΧÐÔÂþÑÜ £¬¿É°éÓм¡Èâѹʹ £¬ºóË÷Óë²àË÷±äÐÔʱÓÐËÄÖ«ÎÞÁ¦¡¢¼¡ÕÅÁ¦ÔöÇ¿¡¢¸¹±Ú·´ÉäÏûÊÅ¡£°Í±ò˹»ùÕ÷¡¢¿¨µÀ¿ËÕ÷ÑôÐÔ¡£²¢ÓоÞϸ±ãʧ½û¡¢¿É°éÓжñÐÔѪÐéµÄ²Ò°× £¬Ïû»¯²»Á¼¼°ÉàÑס£ÖÜΧѪÏó¼°¹ÇËèͿƬ¿É¼û¾Þϸ°ûÐÔ¸ßѪºìÂѰ×ÐÔѪÐé¡£

(ʮһ)¼××´ÅÔÏÙÐÔÄÜ¿º½ø(hyperparathyroidism) Ö÷ÒªÖ¢×´ÓÐÉ༡Õð²ü £¬É༡ήËõ £¬ÀàËÆ¼¡Î®Ëõ²àË÷Ó²»¯Ö¢¡£ÓеĿÉÓÐÉùÒôË»ÑÆ £¬Éù´øÂéľ £¬ÍÌÑÊÄÑÌâ¡£ÉÙÊý²¡È˺ϲ¢ÓÐÉñ¾­ÐÔ¶úÁû»òëì·´É俺½ø £¬ßµÒ»²àëì·´Éäʱ¶Ô²àÖ«ÌåÒà·ºÆð·´Éä»îÔ¾ £¬°Í±ò˹»ùÕ÷ÑôÐÔ¡£ÏÂÖ«½ü¶ËµÄ¼¡Èâ³£Òׯ£ÀͺÍÎÞÁ¦¡£¹ÇÅè´ø¼°¼çëδøµÄ¼¡ÈâÔÚÔ˶¯ºó³£ÓÐÌÛÍ´¼°¸ÐÊÜÒì³£ £¬²¢¿É·ºÆð¼¡Î®Ëõ¡£ÊÜÇÖ¼¡ÈâµÄ¼¡ÕÅÁ¦µÍ £¬ëì·´Éä»îÔ¾¡£±³²¿ÌÛÍ´ £¬²¢°éÓÐѹʹ £¬ÎÞÀο¿²¿Î»¡£

ºã¾ÃÒÔÀ´ALS ȱ·¦ÓÐÓõÄÖÎÁƲ½·¥¡£1995 ÄêÁ¦Â³ßò(Á¦ÈçÌ«)×÷ΪALS µÄ±ê×¼ÖÎÁÆÒ©ÎïÉÏÊкó £¬¾­ÓÉ´ó×ÚµÄÁÙ´²ÑéÖ¤·¢Ã÷¸ÃÒ©¿ÉÑÓÉìALS »¼Õß´¦ÓÚ¼²²¡Çá¡¢ÖжÈ״̬ºÍ´æ»îµÄʱ¼ä £¬ÍƳÙALS ±¬·¢ºôÎüÄÑÌâµÄʱ¼ä £¬µ«²»¿ÉʹÒѾ­·ºÆðµÄÔ˶¯Õϰ­»ñµÃ¸ÄÉÆ¡£¸ÃÒ©Ö÷ÒªÊÇͨ¹ýÒÖÖÆÍ»´¥Ç°¹È°±ËáµÄÊÍ·Å £¬×èÖÍÐË·ÜÐÔ°±»ùËáÊÜÌå £¬ÒÖÖÆÉñ¾­Ä©ÉÒºÍÉñ¾­Ï¸°ûÌåÉϵĵçѹÒÀÀµÐÔÄÆÍ¨µÀ¶øÊ©Õ¹×÷Óá£ÓÃÒ©ÒªÁìΪ50mg £¬2 ´Î/d £¬¿Ú·þ £¬ÁƳÌΪ1¡«1.5 Äê¡£¸ÃÒ©ÄÍÊÜÐԺà £¬³£¼û¸±·´Ó¦ÓжñÐÄ¡¢·¦Á¦ºÍ¹È±ûת°±Ã¸Éý¸ß¡£ALS µÄ¶ÔÖ¢ÖÎÁƶԸÄÉÆ»¼ÕßµÄÉúÑÄÖÊÁ¿¾ßÓÐÖ÷ÒªÒâÒå¡£ÎïÀíÖÎÁÆ¿ÉÑÓ»º¼¡Î®ËõµÄÏ£Íû £¬Ô¤·ÀÊàŦÂÎËõ¡£ÍÌÑʹ¦Ð§Õϰ­Ê±Ó¦ÊµÊ±²åθ¹Ü»òÐÐθÔìðüÊÖÊõ £¬°ü¹ÜÓªÑø¹©Ó¦ £¬×èֹǺ¿Èµ¼ÖµÄÎüÈëÐÔ·ÎÑס£±¬·¢ºôÎüÄÑÌâʱӦÐÐÆø¹ÜÇпª £¬»úÐµÍ¨Æø¡£ ¶ÔÀÍÀÛÐÔºôÎüÄÑÌâµÄ»¼Õ߿ɸø¼äЪÐÔÕýѹ¸¨ÖúºôÎü £¬´ËÖÖ¸¨ÖúºôÎüÆ÷²ÄÌå»ýС £¬²Ù×÷Àû±ã £¬¿ÉËæÉíЯ´ø £¬»¼ÕßÈÝÒ×½ÓÊÜ¡£¶ÔÓÐÍ´ÐÔ¾·ÂλòÑÏÖØ¾·ÂÎ״̬µÄ»¼Õ߿ɸø¿¨ÂíÎ÷ƽ0.1 £¬3 ´Î/d »ò°ÍÂÈ·Ò £¬³õʼ¼ÁÁ¿Îª5mg £¬3 ´Î/d £¬ÒÔºóÿ3 ÌìÔöÌí5mg £¬ÓÐÓüÁÁ¿¹æÄ£Îª30¡«75mg £¬´ó¼ÁÁ¿¿É´ï100¡«120mg¡£

Ïà¹ØÐÂÎÅ

ÁªÏµ·½·¨
µç»°£º0591-38265199
´«Õ棺0591-83228265
ҽѧ×ÉѯÈÈÏߣº400-8875-001
²»Á¼·´Ó¦±¨¸æ£ºÓÊÏ䣺pvd@cosunter.com£»pv@akeylink.cn ÔÚÏßÌ£ºÁ´½Ó
Ò½Ò©´ú±í±¸°¸£ºÁ´½Ó
¹«Ë¾µØµã£º¸£½¨Ê¡¸£ÖݸßÐÂÇøÎÚÁú½­ÖдóµÀ7ºÅÁ¢ÒìÔ°¶þÆÚ16ºÅÂ¥
Éú²ú»ùµØ£º¸£½¨Ê¡èÏÈÙÏØ¶«Ô´Ï縻Դ¹¤ÒµÇø
ɨÂë¹Ø×¢

AGGAME΢ÐŹ«ÖÚºÅ

AGGAME¸ÊÓÑÖ®¼Ò΢ÐŹ«ÖÚºÅ
×ʸñÖ¤Êé±àºÅ£º(Ãö)-·Çı»®ÐÔ-2014-0006 2015 AGGAME ÃöICP±¸11026770ºÅ

Ãö¹«Íø°²±¸ 35092602000113ºÅ

ÍøÕ¾µØÍ¼